Dupilumab Induced Hair Regrowth in Alopecia Totalis

J Drugs Dermatol. 2023 Apr 1;22(4):410-412. doi: 10.36849/JDD.6254.ABSTRACTAlopecia Areata (AA) is an autoimmune process that results in varying degrees of hair loss. Currently, there is no single treatment that has proven to be efficacious in a large cohort of patients. Dupilumab, a human monoclonal antibody recently approved for the treatment of atopic dermatitis, may be a potential treatment option for patients with treatment resistant AA. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.6254 Citation: Bur D, Kim K, Rogge M. Dupilumab induced hair regrowth in alopecia totalis. J Drugs Dermatol. 2023;22(4):410-412. doi:10.36849/JDD.6254.PMID:37026876 | DOI:10.36849/JDD.6254
Source: Journal of Drugs in Dermatology - Category: Dermatology Authors: Source Type: research